Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma
Recruiting
N/A
Interventional Study
Chronic Subdural Hematoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 143 (estimated)
- Sponsor
- Tao Liu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years, male or female;
* Confirmed diagnosis of chronic subdural hematoma (cSDH) by cranial CT and/or MRI;
* Intended for conservative management (i.e., no surgical evacuation indication at enrollment);
* Regular aspirin use at enrollment;
* Informed consent signed by …
Contacts